Wenge ZhongCTO at Regor PharmaceuticalsSpeaker
Profile
Wenge Zhong, CTO & Cofounder of Regor Therapeutics Group. B.S., Beijing University; Ph. D. in Chemistry, California Institute of Technology; Postdoctoral Researcher, The Scripps Research Institute. Prior to Regor, Dr. Zhong worked at Amgen for 18 years, first at Amgen Thousand Oaks for 14 years and later as the Head of Discovery at the Amgen Asia R&D Center in Shanghai. At Regor, Dr. Zhong is responsible for building the cutting-edge innovation engine rCARDTM and leading all discovery programs.
Agenda Sessions
rCARDTM Accelerated Discovery of RGT-075 – A Leading Small Molecule Oral GLP1R Agonist for Obesity and Beyond
, 10:55View Session